Obesity disease management needs to be revolutionised [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Pharma companies, especially the main players in the obesity market, Novo Nordisk and Eli Lilly, have been investing in and developing revolutionary obesity drugs that can achieve unmatched weight loss results and are a great opportunity for obesity patients. However, according to several key opinion leaders (KOLs) interviewed by GlobalData, a leading data and analytics company, the obesity space requires a much greater revolution. Obesity is a chronic metabolic disease characterised by excess weight - it is diagnosed with a body mass index (BMI) over 30kg/m² - and is associated with the development of many other issues, such as Type 2 diabetes, cardiovascular disease, gastrointestinal disorders, respiratory problems, muscular disorders, and psychological issues. Obesity was previously considered a lifestyle choice to be corrected with diet and exercise. In 2013, the American Medical Association voted to recognise obesity as a disease needing treatment and prevention efforts.
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Specialty Enzymes Market worth $9.2 billion by 2029 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Stock market today: Asian shares mostly rise, boosted by Wall Street records as Tesla zooms [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Boeing, Tesla stock reaction, small-cap portfolio: Market Domination Wed, Jul 3, 2024, 12:17 AM GMT+2 0 Video Transcript Advertisement Up next S&P 500, Nasdaq set new record highs, Dow pops by 160 points Tue, Jul 2, 2024, 10:11 PM GMT+2 2 Video TranscriptAcquire Media Monitor
- Boeing, Tesla stock reaction, small-cap portfolio: Market Domination [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 7/2/24 - Form 6-K
- 6/26/24 - Form 6-K
- 6/24/24 - Form 6-K
- NVO's page on the SEC website